Afatinib dimaleate
CAS: 850140-73-7
Ref. 3D-BA162012
| 1g | 3,149.00 € | ||
| 10mg | 146.00 € | ||
| 50mg | 431.00 € | ||
| 200mg | 1,045.00 € | ||
| 500mg | 1,966.00 € |
Product Information
- 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2)
- BIBW2992 DiMaleate
- Bibw 2992Ma2
- Bibw2992-Ma2
- BIBW 2992 dimaleate
Irreversible blocker of three members of the ErbB family (ErbB1, ErbB2/HER2, and ErbB4) with IC50 in nanomolar range. The compound binds covalently to cysteine 797 residue in HER2 and blocks downstream cellular signalling, inhibits cellular growth and promotes apoptosis. Afatinib has been used for the treatment of tyrosine kinase inhibitor-resistant tumours with mutations in ErbB genes, especially for deletions in exon 19 and single nucleotide substitutions in exon 21. It has been used for treatment of non-small cell lung cancer (NSCLC), breast cancer, pancreatic cancer, colorectal cancer, etc.
Chemical properties
Technical inquiry about: 3D-BA162012 Afatinib dimaleate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
